Doximity, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the quarter ended September 30, 2026, the Company’s directors and officers adopted prearranged trading plans intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act as follows:
On August 31, 2026, Mr. Matthew Sonefeldt, Chief Financial Officer of the Company, adopted a Rule 10b5-1 trading plan with a term expiring on August 31, 2027, providing for the sale of up to 17,644 shares of the Company’s Class A common stock and other net vested shares of Class A common stock pursuant to a series of market orders.
On August 11, 2026, Mr. John Vaughan, General Counsel of the Company, adopted a Rule 10b5-1 trading plan with a term expiring on June 1, 2027, providing for the sale of a portion of the shares of the Company’s Class A common stock acquired through the Company’s employee stock purchase plan.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.